CRL Income Statement - TTM - Charles River Laboratories International, Inc.

Income Statement (TTM)

Charles River Laboratories International, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-26	2020 12-26	2021 03-27	2021 06-26	2021 09-25	2021 12-25	2022 03-26	2022 06-25	2022 09-24	2022 12-31	2023 04-01	2023 07-01	2023 09-30	2023 12-30	2024 03-30	2024 06-29	2024 09-28	2024 12-28	2025 03-29	2025 06-28
Revenue	2,824	2,924	3,041	3,273	3,426	3,540	3,630	3,688	3,781	3,976	4,092	4,178	4,216	4,129	4,112	4,078	4,061	4,050	4,023	4,029
Change (%)		3.54	4.02	7.63	4.66	3.33	2.52	1.61	2.53	5.15	2.90	2.12	0.90	-2.05	-0.43	-0.82	-0.41	-0.27	-0.68	0.15
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	1,780	1,850	1,907	2,032	2,138	2,203	2,266	2,310	2,368	2,508	2,580	2,622	2,639	2,600	2,610	2,610	2,618	2,642	2,627	2,618
Change (%)		3.98	3.05	6.59	5.20	3.03	2.89	1.93	2.51	5.92	2.85	1.63	0.66	-1.47	0.39	0.00	0.30	0.90	-0.56	-0.37
% of Revenue	63.01	63.28	62.69	62.09	62.40	62.22	62.44	62.64	62.63	63.09	63.05	62.75	62.60	62.97	63.49	64.02	64.48	65.24	65.31	64.97

Gross Operating Profit	1,045	1,074	1,135	1,241	1,288	1,337	1,363	1,378	1,413	1,468	1,512	1,556	1,577	1,529	1,501	1,467	1,443	1,408	1,395	1,411
Change (%)		2.78	5.69	9.38	3.79	3.83	1.92	1.08	2.55	3.87	3.00	2.97	1.30	-3.01	-1.83	-2.25	-1.69	-2.40	-0.90	1.13
% of Revenue	36.99	36.72	37.31	37.91	37.60	37.78	37.56	37.36	37.37	36.91	36.95	37.25	37.40	37.03	36.51	35.98	35.52	34.76	34.69	35.03

SG&A	501	523	528	566	582	578	578	549	585	656	685	756	752	740	743	711	724	724	723	743
Change (%)		4.27	0.95	7.38	2.78	-0.69	-0.02	-5.10	6.58	12.12	4.55	10.31	-0.57	-1.57	0.47	-4.32	1.83	-0.11	-0.12	2.76
% of Revenue	17.75	17.87	17.34	17.31	16.99	16.33	15.93	14.88	15.46	16.49	16.75	18.09	17.83	17.92	18.08	17.45	17.84	17.87	17.97	18.44

R&D
Change (%)
% of Revenue

OpEx	2,389	2,485	2,547	2,717	2,843	2,906	2,979	2,997	3,094	3,311	3,409	3,518	3,530	3,478	3,482	3,444	3,463	3,504	3,486	3,494
Change (%)		4.03	2.51	6.66	4.64	2.21	2.50	0.64	3.23	6.99	2.97	3.21	0.33	-1.47	0.12	-1.08	0.56	1.17	-0.53	0.23
% of Revenue	84.58	84.98	83.75	83.00	82.98	82.08	82.06	81.27	81.83	83.26	83.31	84.20	83.73	84.22	84.69	84.47	85.29	86.52	86.65	86.72

Operating Income	436	439	494	557	583	634	651	691	687	666	683	660	686	652	630	633	597	546	537	535
Change (%)		0.81	12.57	12.60	4.79	8.77	2.62	6.08	-0.53	-3.12	2.59	-3.29	3.91	-5.00	-3.39	0.60	-5.68	-8.63	-1.64	-0.37
% of Revenue	15.42	15.02	16.25	17.00	17.02	17.92	17.94	18.73	18.17	16.74	16.69	15.80	16.27	15.78	15.31	15.53	14.71	13.48	13.35	13.28

Interest Expense	-78	-86	-101	-98	-96	-74	-54	-41	-36	-59	-84	-116	-138	-137	-137	-135	-132	-126	-119	-116
Change (%)		11.31	16.95	-3.13	-2.46	-22.62	-27.45	-23.29	-12.35	64.43	42.07	37.21	19.35	-0.90	0.45	-1.66	-2.56	-4.04	-5.64	-2.35
% of Revenue	-2.75	-2.96	-3.32	-2.99	-2.79	-2.09	-1.48	-1.12	-0.95	-1.49	-2.06	-2.77	-3.27	-3.31	-3.34	-3.31	-3.24	-3.12	-2.96	-2.89

Net Income	301	364	375	396	397	391	422	443	436	486	496	484	475	475	444	442	424	22	-20	-67
Change (%)		20.85	2.95	5.60	0.13	-1.42	8.05	4.94	-1.57	11.42	2.08	-2.48	-1.88	-0.07	-6.36	-0.66	-4.02	-94.76	-188.53	241.06
% of Revenue	10.67	12.46	12.33	12.10	11.58	11.04	11.64	12.02	11.54	12.23	12.13	11.58	11.27	11.49	10.81	10.83	10.44	0.55	-0.49	-1.66

Source: Capital IQ

GB:0ADA
DE:RV6	€135.75
US:CRL	$152.89
IT:1CRL	€132.15

Charles River Laboratories International, Inc. - Income Statement (TTM)

Income Statement (TTM)

Other Listings